Researchers reveal that eosinophils suppress chordoma growth, highlighting its potential as an immunotherapeutic target ...
In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...
Researchers identified a gene niche that promotes liver tumorigenesis and built a machine-learning score to detect it. The ...
Closed, diagnosis-specific online communities provided psychologically safe space for young breast cancer survivors to ...
Oslo, Norway, 17 February 2026 – Oncoinvent, a biotech developing a receptor-independent alpha radiopharmaceutical to ...
Biologic therapies are safe for use in patients with psoriasis who also have active or recent cancer when compared with conventional therapies.
Researchers at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk ...
A retrospective study shows a synergistic interaction between Parkinson disease and stroke, leading to increased long-term mortality risk.
The REPLENISH trial finds secukinumab doubles the remission rate and significantly lowers steroid use in relapsing ...
The Binary Coin Days Destroyed (Binary CDD), which tracks whether long-term investors are moving dormant coins, currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results